Chondrosarcoma of the nasal cavity in a patient with Maffucci syndrome: case report and review of the literature
© Steinbichler et al.; licensee BioMed Central. 2014
Received: 22 July 2014
Accepted: 3 December 2014
Published: 17 December 2014
Maffucci syndrome is a rare, congenital, non-hereditary mesodermal dysplasia, manifested by multiple enchondromas and hemangiomas. Malignant transformation of these lesions is seen in up to 40% of the cases.
We present a case of a patient with Maffucci syndrome and an associated chondrosarcoma of the nose. Treatment consisted of surgical resection. Because of the low grade of the tumor, additional treatment, such as radiotherapy, was not necessary.
Maffucci syndrome is an exceedingly rare mesodermal dysplasia. Its manifestation in the head and neck region is even less common. Malignant transformation of the associated enchondromas is common, and should be considered whenever a change of the clinical course occurs. Random, periodically performed X-ray examinations give little additional information on malignant transformation and are considered useless.
KeywordsChondrosarcoma Enchondroma Hemangioma Maffucci syndrome
Maffucci syndrome is a rare, non-hereditary mesodermal dysplasia. It is characterized by multiple enchondromas and hemangiomas, especially in the extremities . A manifestation in the head and neck region is rare. There are only two case reports that describe a primary involvement of the nasal cavities and paranasal sinuses [2, 3].
The enchondromas usually develop near to growth plate cartilage and may result from deregulated proliferation and differentiation of chondrocytes during physiological enchondral ossification . Complications include spontaneous fracture, resulting in skeletal deformity and the possibility of malignant transformation in up to 40% of the cases .
Three types of vascular lesions are associated with Maffucci syndrome: cavernous hemangiomas, phlebectasias and lymphangiectasia-lymphangiomas .
The syndrome can be associated with benign and malignant tumors, like parathyroid and pituitary adenoma, astrocytoma and breast cancer .
The disease occurs usually in one side of the body. The bone and vascular lesions develop at birth or in early childhood and may be progressive [5, 6]. The average age at diagnosis is 12 years and diagnosis is made on clinical grounds .
Surgical intervention is not required in the absence of complications .
Cartilaginous tumors of the head and neck are rare. The most frequent sites are the larynx and spheno-ethmoidal region. Typical clinical symptoms of cartilaginous nasal tumors include nasal mass, obstruction, headache and epistaxis. The therapy is wide surgical excision .
A 39-year-old white woman presented to the Department of Otorhinolaryngology-Head and Neck surgery, Medical University of Innsbruck, with an 18-month history of nasal obstruction. One year ago, an ambulatory ear, nose and throat examination and tissue biopsy had revealed a chondroma of the left nasal cavity. Surgical resection at that time was not possible because of gravidity. The patient was now presenting to our clinic because of a worsening of symptoms during the last few weeks.
The initial endoscopic evaluation revealed a large mass in the left nasal cavity with no signs of inflammation or destruction of surrounding tissue.
A complete surgical resection of the tumor was decided. The tumor was resected via a transnasal endoscopic approach with the help of computer-assisted navigation. During surgery, the smooth and lobulated tumor was found to have infiltrated the nasal septum and the anterior wall of the sphenoid sinus. Consequently the posterior part of the nasal septum and the anterior wall of the sphenoid sinus had to be removed, resulting in a permanent connection of both nasal cavities. The tumor was affecting the left maxillary sinus but without infiltration of the surrounding bone, so it could easily be removed. All surrounding bony structures were smoothed with a sinus drill device. Frozen sections were taken from the margins and confirmed complete tumor resection.
Possible surgical complications could be divided into intracranial, orbital and local complications. Local complications include anosmia, bleeding and septal abscess. Intracranial complications include rhinoliquorrhoea leading to meningitis, encephalitis or intracranial abscesses. Possible orbital complications include double vision resulting from motility dysfunction, loss of vision, and orbital infections or intraorbital hematoma. Postoperatively, none of these complications was noted.
Because of the complete surgical resection of the chondrosarcoma, no additional radiotherapy was necessary. The interdisciplinary head and neck tumor board decided on a clinical follow-up. Because of the recurrent hemangiomas, therapy with propranolol (Inderal; Astra Zeneca Inc., Vienna, Austria) was initiated.
Chondrosarcomas are the third most common type of primary bone tumors (after osteosarcoma and myeloma) . Only 10% are found in the head and neck region . According to our histological findings the majority of chondrosarcomas of the skull base are conventional chondrosarcomas with good or moderate differentiation. Other rare types that present at the skull base are poor differentiated mesenchymal chondrosarcomas or extraskeletal myxoid chondrosarcoma .
The mean age at diagnosis varies between 30 and 60 years . Presenting symptoms are nasal mass and obstruction and depend on the involvement of adjacent structures . The main affected sites are the sphenoid and maxillary sinus . Overall survival after 5 years is estimated at 80.7% , depending on size, localization and grade . The metastasis rate is higher in primary and dedifferentiated chondrosarcomas than in secondary ones .
Surgical resection is the most effective therapy. The resection margins should be determined in relation to the grade of differentiation of the tumor. While wide bloc excision is recommended for high-grade chondrosarcomas, local curettage is sufficient for low-grade tumors. Because of the low percentage of dividing cells, poor vascularization and the production of extracellular matrix, chondrosarcomas are relatively radio- and chemotherapy resistant. Radiotherapy is feasible after incomplete resection or whenever resection is not possible, to achieve local control .
Patients with Maffucci syndrome have a 25% to 30% risk of developing chondrosarcomas and are usually younger than those with primary chondrosarcoma . The chondrosarcomas usually present at the upper and lower extremities. An involvement of the head and neck region in Maffucci syndrome is exceedingly rare . Enchondromas of the axial skeleton have a higher risk of malignant transformation than those found in the smaller bones of the extremities. Enchondromas in patients with Maffucci syndrome have a more locally aggressive growth pattern, so that the differential diagnosis towards a low-grade chondrosarcoma is even more difficult than usual .
Random, periodically performed X-ray examinations give little additional information on malignant transformation and are considered useless. Changes in the clinical symptoms should be an indication for surgical intervention rather than radiological findings . The clinical symptoms our patient presented with determined the immediate surgical intervention in this case. Additional therapy was not necessary because of the low grade of the lesion, for which regional curettage is sufficient .
Maffucci syndrome is an exceedingly rare mesodermal dysplasia. Malignant transformation of the associated enchondromas is common, and should be considered whenever a change of the clinical course occurs. If complete surgical resection can be achieved, no additional treatment like radiotherapy is necessary. The prognosis of these chondrosarcomas is quite favorable.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
TS is an assistant doctor, FK is a medical specialist for Otorhinolaryngology, and HR is a medical specialist for Otorhinolaryngology and Head of Department, all within the Department of Otorhinolaryngology, Head and Neck Surgery, Medical University Innsbruck, Austria. SR is an assistant doctor within the Department of Pathology, Medical University Innsbruck, Austria.
- Verdegaal SHM, Bovée JVMG, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC, San Julian M, Biau DJ, van der Geest IC, Leithner A, Streitbürger A, Klenke FM, Gouin FG, Campanacci DA, Marec-Berard P, Hogendoorn PC, Brand R, Taminiau AH: Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011, 16 (12): 1771-1779. 10.1634/theoncologist.2011-0200.PubMed CentralView ArticlePubMedGoogle Scholar
- Jacobi CM, Hiranya ES, Gay A, Holzmann D, Kollias S, Soyka M: Enchondroma of the nasal septum due to Ollier disease: a case report and review of the literature. Head Neck. 2014, [Epub ahead of print]Google Scholar
- Hyde GE, Yarington CT, Chu FW: Head and neck manifestations of Maffucci’s syndrome: chondrosarcoma of the nasal septum. Am J Otolaryngol. 1995, 16 (4): 272-275. 10.1016/0196-0709(95)90157-4.View ArticlePubMedGoogle Scholar
- Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, McCarthy S, Fantin VR, Straley KS, Lobo S, Aston W, Green CL, Gale RE, Tirabosco R, Futreal A, Campbell P, Presneau N, Flanagan AM: Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet. 2011, 43 (12): 1262-1265. 10.1038/ng.994.View ArticlePubMedGoogle Scholar
- Jermann M, Eid K, Pfammatter T, Stahel R: Maffucci’s syndrome. Circulation. 2001, 104 (14): 1693-10.1161/hc3901.096180.View ArticlePubMedGoogle Scholar
- Gao H, Wang B, Zhang X, Liu F, Lu Y: Maffucci syndrome with unilateral limb: a case report and review of the literature. Chin J Cancer Res. 2013, 25 (2): 254-258.PubMed CentralPubMedGoogle Scholar
- Pannier S, Legeai-Mallet L: Hereditary multiple exostoses and enchondromatosis. Best Pract Res Clin Rheumatol. 2008, 22 (1): 45-54. 10.1016/j.berh.2007.12.004.View ArticlePubMedGoogle Scholar
- Scierski W, Namysłowski G, Misiołek M, Widziszowska A, Hajduk A: Septal nasal chondroma–a case report. Otolaryngol Pol. 2007, 61 (6): 1021-1023. 10.1016/S0030-6657(07)70575-9.View ArticlePubMedGoogle Scholar
- Dai X, Ma W, He X, Jha RK: Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing’s sarcoma. Med Sci Monit. 2011, 17 (8): RA177-RA190.PubMed CentralView ArticlePubMedGoogle Scholar
- Kharrat S, Sahtout S, Tababi S, Temimi S, Ben Miled M, Abid W, Zainine R, Nouira K, Menif E, Beltaief N, Besbes G: Chondrosarcoma of sinonasal cavity: a case report and brief literature review. Tunis Med. 2010, 88 (2): 122-124.PubMedGoogle Scholar
- Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, Liebsch NJ: Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999, 23 (11): 1370-1378. 10.1097/00000478-199911000-00007.View ArticlePubMedGoogle Scholar
- Lee DH, Jung SH, Yoon TM, Lee JK, Joo YE, Lim SC: Low grade chondrosarcoma of the nasal septum. World J Clin Cases. 2013, 1 (1): 64-66. 10.12998/wjcc.v1.i1.64.PubMed CentralView ArticlePubMedGoogle Scholar
- Guo L, Liu J, Sun X, Wang D: Sinonasal tract chondrosarcoma: 18-year experience at a single institution. Auris Nasus Larynx. 2013, 41 (3): 290-293.View ArticlePubMedGoogle Scholar
- Saito K, Unni KK, Wollan PC, Lund BA: Chondrosarcoma of the jaw and facial bones. Cancer. 1995, 76 (9): 1550-1558. 10.1002/1097-0142(19951101)76:9<1550::AID-CNCR2820760909>3.0.CO;2-S.View ArticlePubMedGoogle Scholar
- Mahajan AM, Ganvir S, Hazarey V, Mahajan MC: Chondrosarcoma of the maxilla: a case report and review of literature. J Oral Maxillofac Pathol. 2013, 17 (2): 269-273. 10.4103/0973-029X.119759.PubMed CentralView ArticlePubMedGoogle Scholar
- Ozaki T, Hillmann A, Linder N, Blasius S, Winkelmann W: Metastasis of chondrosarcoma. J Cancer Res Clin Oncol. 1996, 122 (10): 629-632. 10.1007/BF01221196.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.